SLC39A14 and Cachexia: Knowledge of the specific factors that regulate Zip14 induction in muscle cells in the Bard1‐deficient, orthotopic model could therefore inform new therapeutic opportunities to prevent or reverse cachexia in triple‐negative breast cancer models with disrupted Brca1/Bard1 function.